Lung Adverse Effects in Patients Taking Trastuzumab Deruxtecan

Cancer patients treated with the targeted agent need to be closely monitored for interstitial lung disease/pneumonitis as an adverse event, say researchers reporting a new analysis.
Medscape Medical News

source https://www.medscape.com/viewarticle/979376?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?